Cargando…
First clinical experience in 14 patients treated with ADVOS: a study on feasibility, safety and efficacy of a new type of albumin dialysis
BACKGROUND: Liver failure (LF) is associated with prolonged hospital stay, increased cost and substantial mortality. Due to the limited number of donor organs, extracorporeal liver support is suggested as an appealing concept to “bridge to transplant” or to avoid transplant in case of recovery. ADVa...
Autores principales: | Huber, Wolfgang, Henschel, Benedikt, Schmid, Roland, Al-Chalabi, Ahmed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312588/ https://www.ncbi.nlm.nih.gov/pubmed/28209134 http://dx.doi.org/10.1186/s12876-017-0569-x |
Ejemplares similares
-
First clinical experience with a new type of albumin dialysis: the HepaWash® system
por: Henschel, B, et al.
Publicado: (2015) -
Evaluation of an ADVanced Organ Support (ADVOS) system in a two-hit porcine model of liver failure plus endotoxemia
por: Al-Chalabi, Ahmed, et al.
Publicado: (2017) -
Extracorporeal multiorgan support including CO(2)-removal with the ADVanced Organ Support (ADVOS) system for COVID-19: A case report
por: Huber, Wolfgang, et al.
Publicado: (2020) -
Advanced organ support (ADVOS) in the critically ill: first clinical experience in patients with multiple organ failure
por: Fuhrmann, Valentin, et al.
Publicado: (2020) -
Influence of Advanced Organ Support (ADVOS) on Cytokine Levels in Patients with Acute-on-Chronic Liver Failure (ACLF)
por: Kaps, Leonard, et al.
Publicado: (2022)